PrimeRFP SCOUT · Federal Contract Recompete Brief

75N90026P00081Director of quality assurance for CCE — Propharma Group LLC

Propharma Group LLC holds $3.1M across 15 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Jan 30, 2027 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health - Cc

Awarding office

Propharma Group LLC

Recipient

Jan 30, 2027

PoP end

$416K

Obligated

$416K

Potential

541611

NAICS

R408

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Propharma Group LLC — $90

Contract facts

NONE

Contract number75N90026P00081

AgencyNational Institutes Of Health - Cc

Awarding officeNational Institutes Of Health - Cc

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentPropharma Group LLC

CAGE57X20

UEIN6C8UMMHCB15

NAICS541611

PSCR408

Place of performanceBETHESDA MD

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startJan 31, 2026

PoP end (current)Jan 30, 2027

Obligated$416K

Current value$416K

Potential value$416K

DIRECTOR OF QUALITY ASSURANCE FOR CCE is a federal NONE award for National Institutes Of Health - Cc held by Propharma Group LLC. Estimated value $416K ($416K obligated). Current period of performance ends Jan 30, 2027. Last award drew 1 bidder. Place of performance: BETHESDA MD.

Recompete timing

Public

● Expiring in 145 days

Current PoP ends Jan 30, 2027 (145 days remaining). Agencies typically plan 12–18 months ahead — at 4.8 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Propharma Group LLC — $3.1M obligated across 15 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.1M) · all agencies

Department of Health and Human Services (HHS)$3.1M · 100%Department of Veterans Affairs (VA)$22K · 1%

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N90026P00081?

75N90026P00081 (Director of quality assurance for CCE) is a National Institutes Of Health - Cc award with a potential value of $416K, currently held by Propharma Group LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N90026P00081?

National Institutes Of Health - Cc awarded 75N90026P00081 to Propharma Group LLC (potential $416K).

Who is the incumbent on 75N90026P00081?

Propharma Group LLC is the incumbent with $3.1M across 15 related awards in SCOUT’s public footprint. The current period of performance ends Jan 30, 2027.

When does Propharma Group LLC’s 75N90026P00081 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N90026P00081 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Jan 29, 2026